Evidence map›Paper›PMID 34853694›Full record

ReviewEvolution, medicine, and public health2021

Five reasons COVID-19 is less severe in younger age-groups.

Paul W Turke

Open access · goldAbstract readReview
In one paragraph

Review in Evolution, medicine, and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. COVID-19 andEvolution, medicine, and public health · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. One Year of the COVID-19 Pandemic in Galicia: A Global View of Age-Group Statistics during Three Waves.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Paul W TurkeTurke & Thomashow Pediatrics, 7444 Dexter-Ann Arbor Rd, Dexter, MI 48130, USA.ORCID https://orcid.org/0000-0001-8957-6329

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The severity of COVID-19 is age-related, with the advantage going to younger age-groups. Five reasons are presented. The first two are well-known, are being actively researched by the broader medical community, and therefore are discussed only briefly here. The third, fourth and fifth reasons derive from evolutionary life history theory, and potentially fill gaps in current understanding of why and how young and old age-groups respond differently to infection with SARS-CoV-2. Age of onset of generalized somatic aging and the timing of its progression are identified as important causes of these disparities, as are specific antagonistic pleiotropic tradeoffs in immune system function.

Indexed as

antagonistic pleiotropyCOVID-19crowd diseaseslife history theorySARS-CoV-2T cells

Identifiers

PMID34853694
PMCPMC7799091
OpenAlexW3116978821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.